Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NIP Group Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
-
Liberty Global Reports Q2 2026 Results
-
First Hawaiian, Inc. Reports Second Quarter 2026 Financial Results and Declares Dividend
-
OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026
-
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
-
Teamshares to Release Second Quarter 2026 Earnings on August 14, 2026
-
Exyn Defense Expands into Multi-Billion-Dollar Defense Sustainment Market, Bringing Field-Proven AI Autonomy to U.S. Air Force Aircraft Readiness
-
Signorelli Unveils 55-Acre Commerce District at Valley Ranch
-
Gentex Reports Second Quarter 2026 Financial Results
-
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Co
-
Amwell® to report second quarter 2026 operating results
-
Mission Critical Group and CORE Transformers Enter into Merger Agreement
-
United Nations Environment Programme Recognizes Lead Service Line Replacement Cost Calculator
-
SEA Index® extends CO₂ certification to the whole recreational yachting sector
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
-
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
-
Tax Goddess Disrupts CPA Model with Flat-Rate Strategy Tiers to Protect HNW Wealth
-
CN Declares Third-Quarter 2026 Dividend
-
AGF Investments Announces July 2026 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Enhanced U.S. Income Plus Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure
-
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
-
Postal Realty Trust, Inc. to Report Second Quarter 2026 Financial Results on August 4, 2026
-
CN Delivers on Commitments with Strong Second Quarter Results and Raises 2026 Guidance
-
Dyadic Announces Continued Listing on the Nasdaq Capital Market
-
GreenHat Announces Successful Delegation at Web Summit Vancouver 2026
-
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
-
SPIRIT BLOCKCHAIN CAPITAL APPOINTS SUHA ASKARY AS CHIEF EXECUTIVE OFFICER
-
Director/PDMR Shareholding
-
The BANK of Greenland early redemption of Senior Non-Preferred capital
-
Issue of Equity
-
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
-
Noodles & Company Announces Second Quarter 2026 Financial Results
-
Toronto's largest park in a generation just got bigger: Biidaasige Park opens 10 new acres of waterfront public space
-
Glass Lewis Joins ISS in Supporting XFLT's Proposal to Approve the King Street Sub-Advisory Agreement Ahead of Special Meeting
-
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
-
Verizon Delivers Record 2Q26 Results as Strategic Transformation Ignites Accelerated Growth
-
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Second Quarter Ended June 30, 2026 Financial Results
-
Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Costamare Inc. Sets the Date for Its Second Quarter 2026 Results Release
-
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
-
Bullish announces Siris to acquire non-core Equiniti business lines
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
MannKind Announces $50 Million Private Placement
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
A.I.S. Resources Unveils New Website and Corporate Presentation
-
Nova Minerals Highlights Strategic Alignment with U.S. Defense Supply Chain Priorities Under White House Executive Order
-
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic K
-
Einride to Host First Half 2026 Earnings Conference Call on August 18, 2026
-
Form 8.5 (EPT/RI) - Alternative Income REIT plc
